Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: results of cancer and leuk (Q73181830)
Jump to navigation
Jump to search
scientific article published on 01 September 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: results of cancer and leuk |
scientific article published on 01 September 1999 |
Statements
Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: results of cancer and leukemia group B study 9420 (English)
E J Lee
S L George
M Caligiuri
T P Szatrowski
B L Powell
S Lemke
R K Dodge
R Smith
M Baer
C A Schiffer
1 September 1999